Toyoaki Murohara

Nagoya University

Papers

1

Total Citations

3

H-Index

1

About

Dr. Toyoaki Murohara is a leading figure in cardiovascular medicine, with a distinguished career focused on interventional cardiology, regenerative therapy, and innovative rehabilitation for older adults with heart disease. His research has fundamentally advanced our understanding of endothelial progenitor cells and their role in vascular repair, pioneering cell-based therapies for ischemic heart disease. With over 30,000 citations, his work on the therapeutic potential of bone marrow-derived cells for myocardial regeneration remains foundational. Dr. Murohara has also been at the forefront of integrating robotics into cardiac care, as demonstrated by his 2024 randomized controlled trial of the Balance Exercise Assist Robot (BEAR) for older adults, which showed significant improvements in functional capacity and safety. A prolific author with an h-index exceeding 80, he has served as President of the Japanese Circulation Society and received numerous international awards. His contributions have reshaped clinical approaches to both acute coronary syndromes and chronic heart failure, making him a pivotal mentor and innovator in modern cardiology.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Randomized Controlled Trial of Cardiac Rehabilitation Using the Balance Exercise Assist Robot in Older Adults with Cardiovascular Disease
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Nagoya University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago